Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $56.31

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $56.31.

Several brokerages have issued reports on ACHC. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Bank of America decreased their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Barclays lowered Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $43.00 to $35.00 in a report on Friday, February 28th. Royal Bank of Canada lowered their price target on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Finally, TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th.

Acadia Healthcare Price Performance

ACHC opened at $29.14 on Wednesday. Acadia Healthcare has a 1 year low of $27.61 and a 1 year high of $82.41. The stock has a 50-day moving average price of $39.52 and a 200-day moving average price of $47.57. The firm has a market cap of $2.71 billion, a PE ratio of 9.55, a P/E/G ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Phocas Financial Corp. increased its position in shares of Acadia Healthcare by 30.6% during the 4th quarter. Phocas Financial Corp. now owns 94,320 shares of the company’s stock valued at $3,740,000 after purchasing an additional 22,095 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in Acadia Healthcare in the fourth quarter worth approximately $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Acadia Healthcare by 22.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company’s stock worth $12,439,000 after acquiring an additional 56,647 shares during the last quarter. Voloridge Investment Management LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter worth $15,770,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Acadia Healthcare in the 4th quarter worth $1,087,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.